Prof. Dr. med. Peter Fasching

Department of Obstetrics and Gynaecology Professur für Translationale Frauenheilkunde und Geburtshilfe

Real-world progression-free survival and overall survival in patients with HR+/HER2− advanced breast cancer treated in first-line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study (2026) Fasching P, Brucker C, Decker T, Engel A, Göhler T, Jackisch C, Janssen J, et al. Journal article Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study (2026) Kuemmel S, Fasching P, Schmid P, Harbeck N, Takahashi M, Untch M, Boileau JF, et al. Journal article ABC8 Consensus: Assessment by a German Group of Experts (2026) Ditsch N, Untch M, Fasching P, Briest S, Ettl J, Haidinger R, Lüftner D, et al. Journal article Acceptance, Perceived Usefulness, and Data Sharing in Mobile Health Apps Among Patients With Breast Cancer: Cross-Sectional Survey Study (2026) Flaucher M, Ott T, Nissen M, Dabrock P, Hübner H, Beckmann M, Fasching P, et al. Journal article Chemotherapy-Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline-Free Regimen With Docetaxel, Cyclophosphamide—Results From a Randomized Clinical Trial (2026) Hörner M, Schäffler H, Häberle L, Goossens C, Pfister K, Leinert E, Veselinovic K, et al. Journal article Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025) Conforti F, Holtschmidt J, Nekljudova V, Sala I, Pagan E, Solbach C, Untch M, et al. Journal article Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX) (2025) Link T, Reinisch M, Just M, Untch M, Filmann N, Stötzer O, Denkert C, et al. Journal article Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality (2025) Lehle S, Völkl S, Seitz K, Goossens C, Emons J, Rübner M, Uhrig S, et al. Journal article Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer (2025) Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, et al. Journal article Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial (2025) Kolberg HC, Schumacher J, Erber R, Braun M, Fasching P, Grischke EM, Schem C, et al. Journal article